Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate
![BK9C81 | 2095311-51-4 | Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate](https://qncdn.chemcd.cn/alchemypharm/2095311-51-4.png "BK9C81 | 2095311-51-4 | Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate")
Catalog No.: BK9C81
CAS.RN：2095311-51-4
Molecular Formula: C22H23N5O2
Molecular Weight: 389.45 g/mol
Purity: NLT 98%
Intermediates of Upadacitinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA1R4F | Upadacitinib API | 1310726-60-3 |
| BK9C81 | Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate | 2095311-51-4 |
| BK319Y | (3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt | 2095311-49-0 |
| BK5B3X | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester | 1869118-24-0 |
| BK711A | N-Tosyl-5-bromo-4,7-diazaindole | 1201186-54-0 |
| BK35UU | 5-Bromo-4,7-diazaindole | 875781-43-4 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
